NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.
For over 85 years, Sleepwell has been providing retailers and their consumers with the best quality mattresses and bedding on the market. Servicing Maryland, Delaware, Washington, D.C., New Jersey, Pennsylvania, Virginia, North Carolina, and Tennessee, Sleepwell is certain to meet your unique needs. Contact us today at 301-322-1000!
ZYPPAH, Inc. is an A+ rated company with thousands of five-star customer reviews for ZYPPAH anti-snoring solutions. All ZYPPAH products are safe and effective, manufactured in the USA, BPA free, and cleared by the FDA. Dr. Jonathan Greenburg, Founder, and CEO, and inventor of the ZYPPAH devices, which are the only ones that use a patented stabilizing band for the tongue, which is the root cause for snoring. Other solutions for snoring do not specifically address the tongue, and therefore may not work as well or at all. Clinical testing performed by an independent party on ZYPPAH devices shows that the tongue band is a clear differentiator over other snoring mouthpieces that do not offer this component.